Salmetrol + Fluticasone 25/250
Flumetol inhaler is a pressurized metered dose inhaler. It is intended for oral inhalation only. It is a combination of Salmeterol Xinafoate BP and Fluticasone Propionate BP. Salmeterol Xinafoate is a selective, long-acting beta-2-agonist used in the treatment of asthma and other forms of diffuse airways obstruction. Fluticasone Propionate is a corticosteroid with mainly glucocorticoid activity. Fluticasone Propionate is stated to exert a topical effect on the lungs without systematic effects at usual dose.
Flumetol® is indicated in the regular treatment of asthma where use of a combination product (long-acting beta-2 -agonist and inhaled corticosteroid) is appropriate:
– Patients not adequately controlled with inhaled corticosteroids and as needed inhaled short acting beta-2-agonist. or
– Patients already adequately controlled on both inhaled corticosteroids and long-acting beta-2-agonist.